First Few Cases Study to Investigate Clinical and Epidemiological Characteristics of COVID-19 in the Early Phase of the Response, Sierra Leone 2020

Kamara Kassim, Gebru Gebrekrstos Negash Gebru, Namwase Angella Sandra, Squire James Sylvester, Foster Monique, Singh Tushar, Sloan Michelle L
{"title":"First Few Cases Study to Investigate Clinical and Epidemiological Characteristics of COVID-19 in the Early Phase of the Response, Sierra Leone 2020","authors":"Kamara Kassim, Gebru Gebrekrstos Negash Gebru, Namwase Angella Sandra, Squire James Sylvester, Foster Monique, Singh Tushar, Sloan Michelle L","doi":"10.23937/2474-3658/1510274","DOIUrl":null,"url":null,"abstract":"Background: Sierra Leone reported its first case of COVID-19 on March 30, 2020. This report describes the clinical characteristics and the epidemiological features of the first few cases and contacts of COVID-19 in Sierra Leone. Methods: A prospective case-ascertained study was conducted to identify contacts of laboratory-confirmed COVID-19 cases. Demographic, socio-economic, and clinical presentations were collected. Specimen were collected on day 1, day 7, and days 14-21. Data was analyzed using R, Stata, and Microsoft Excel. Results: The study included 160 cases and 1,003 contacts (56% males, 66% age 15-49 years). Of the total, 101/160 (63.1%) were primary cases, 59/160 (36.9%) secondary cases. Common symptoms reported included cough (39/160, 24.4%), headache (35/160, 21.9%), and fatigue (29/160, 18.1%). However, 55% (88/160) of the cases were asymptomatic at enrollment, and 83% (49/59) of the secondary cases were exposed to asymptomatic primary cases. The secondary infection rate was 5.8%. Almost 97% of the secondary cases tested positive on day 1and 3.4% on day 7. Pre-existing medical conditions among cases included diabetes and obesity. Conclusions: We were able to identify clinical and epidemiological characteristics of 160 COVID-19 cases in the early phase of the pandemic in Sierra Leone. The findings of this study helped the Government of Sierra Leone develop and revise its policies and response strategies in order to reduce preventable COVID-19-related deaths. Early investigational protocols such as the first few cases study can be of great utility during outbreaks of relatively unknown diseases. What is already known on this topic A cluster of unusual pneumonia cases was reported in Wuhan, China, that was later identified to be caused by the novel coronavirus, severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. However, limited knowledge exists on the epidemiological and clinical characteristics of SARS-CoV-2 and the outbreak dynamics at the time Sierra Leone detected its first case. What this study adds This study helped to understand the key clinical characteristics of COVID-19 cases and epidemiological features of COVID-19 diseases in Sierra Leone. Implications of the study in practice, or policy The findings of this study provided evidence for targeted and specific prevention and control measures to contain the spread of the disease in Sierra Leone.","PeriodicalId":93465,"journal":{"name":"Journal of infectious diseases and epidemiology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of infectious diseases and epidemiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23937/2474-3658/1510274","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Sierra Leone reported its first case of COVID-19 on March 30, 2020. This report describes the clinical characteristics and the epidemiological features of the first few cases and contacts of COVID-19 in Sierra Leone. Methods: A prospective case-ascertained study was conducted to identify contacts of laboratory-confirmed COVID-19 cases. Demographic, socio-economic, and clinical presentations were collected. Specimen were collected on day 1, day 7, and days 14-21. Data was analyzed using R, Stata, and Microsoft Excel. Results: The study included 160 cases and 1,003 contacts (56% males, 66% age 15-49 years). Of the total, 101/160 (63.1%) were primary cases, 59/160 (36.9%) secondary cases. Common symptoms reported included cough (39/160, 24.4%), headache (35/160, 21.9%), and fatigue (29/160, 18.1%). However, 55% (88/160) of the cases were asymptomatic at enrollment, and 83% (49/59) of the secondary cases were exposed to asymptomatic primary cases. The secondary infection rate was 5.8%. Almost 97% of the secondary cases tested positive on day 1and 3.4% on day 7. Pre-existing medical conditions among cases included diabetes and obesity. Conclusions: We were able to identify clinical and epidemiological characteristics of 160 COVID-19 cases in the early phase of the pandemic in Sierra Leone. The findings of this study helped the Government of Sierra Leone develop and revise its policies and response strategies in order to reduce preventable COVID-19-related deaths. Early investigational protocols such as the first few cases study can be of great utility during outbreaks of relatively unknown diseases. What is already known on this topic A cluster of unusual pneumonia cases was reported in Wuhan, China, that was later identified to be caused by the novel coronavirus, severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. However, limited knowledge exists on the epidemiological and clinical characteristics of SARS-CoV-2 and the outbreak dynamics at the time Sierra Leone detected its first case. What this study adds This study helped to understand the key clinical characteristics of COVID-19 cases and epidemiological features of COVID-19 diseases in Sierra Leone. Implications of the study in practice, or policy The findings of this study provided evidence for targeted and specific prevention and control measures to contain the spread of the disease in Sierra Leone.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
调查新冠肺炎早期反应的临床和流行病学特征的首批病例研究,塞拉利昂2020
背景:塞拉利昂于2020年3月30日报告了其首例新冠肺炎病例。本报告描述了塞拉利昂首批新冠肺炎病例和接触者的临床特征和流行病学特征。方法:进行前瞻性病例确定研究,以确定实验室确诊的新冠肺炎病例的接触者。收集人口统计学、社会经济和临床表现。在第1天、第7天和第14-21天采集标本。使用R、Stata和Microsoft Excel对数据进行分析。结果:该研究包括160例病例和1003名接触者(56%为男性,66%为15-49岁)。在总数中,101/160例(63.1%)为原发性病例,59/160例(36.9%)为继发性病例。报告的常见症状包括咳嗽(39/160,24.4%)、头痛(35/160,21.9%)和疲劳(29/160,18.1%)。然而,55%(88/160)的病例在登记时无症状,83%(49/59)的继发病例接触无症状原发病例。二次感染率为5.8%。几乎97%的二次感染病例在第1天和第7天检测呈阳性。病例中先前存在的疾病包括糖尿病和肥胖症。结论:我们能够确定塞拉利昂疫情早期160例新冠肺炎病例的临床和流行病学特征。这项研究的结果有助于塞拉利昂政府制定和修订其政策和应对战略,以减少可预防的新冠肺炎相关死亡。早期研究方案,如前几个病例研究,在相对未知的疾病爆发期间可能会非常有用。关于这一主题的已知情况中国武汉报告了一组不寻常的肺炎病例,后来被确定为由新型冠状病毒、严重急性呼吸综合征冠状病毒2型或SARS-CoV-2引起。然而,在塞拉利昂发现首例病例时,对严重急性呼吸系统综合征冠状病毒2型的流行病学和临床特征以及疫情动态的了解有限。本研究补充内容本研究有助于了解塞拉利昂新冠肺炎病例的关键临床特征和新冠肺炎疾病的流行病学特征。这项研究的结果为有针对性和具体的预防和控制措施提供了证据,以遏制疾病在塞拉利昂的传播。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Seropositivity of Anti-CMV IgM Antibody among Women of Child-Bearing Age Attending Selected Hospitals in Kaduna State, Nigeria Knowledge, Attitude and Risk Factors of Acquiring Leptospirosis and Other Rodent-Borne Diseases in Kibondo and Kakonko Districts, Kigoma, Tanzania Variability of Hepatitis B Genotypes among HIV Infected Individuals in Kenya Antimalarial Health Seekers' Preferences and Perceptions: Insights from Ghana Knowledge, Attitude and Practice Survey on Protective Behavioral Practices against Coronavirus Disease 2019 among Health Workers in Sierra Leone, 2020
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1